XML 46 R36.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of stock-based compensation expense
The following two tables summarize our total stock-based compensation expense by award type and where the stock-based compensation expense was recorded in our consolidated statements of operations (in thousands):
Three Months Ended March 31,
20212020
(unaudited)
Options$1,394 $2,542 
Restricted stock units8,002 5,117 
Performance-based restricted stock units1,329 — 
Employee stock purchase plan417 492 
Restricted shares2,368 590 
Total stock-based compensation$13,510 $8,741 
Three Months Ended March 31,
20212020
(unaudited)
Cost of revenue$1,809 $992 
Sales and marketing4,818 3,182 
Research and development2,257 1,882 
General and administrative4,626 2,685 
Total stock-based compensation$13,510 $8,741 
Schedule of information related to stock options A summary of the share option activity under the 2019 Plan for the three months ended March 31, 2021, is as follows:
Time-Based Option SharesWeighted Average Exercise PriceWeighted Average Remaining Contractual Life in YearsAggregate Intrinsic Value
(unaudited)
Outstanding at January 1, 2021
3,892,936 $11.58 
Options exercised(537,889)12.05 
Options cancelled/forfeited(11,000)11.50 
Outstanding at March 31, 2021
3,344,047 $11.50 6.8$117,946,252 
Vested and expected to vest as of March 31, 2021
3,344,047 $11.50 6.8$117,946,252 
Vested and exercisable as of March 31, 2021
1,715,358 $10.49 6.0$62,231,385 
Schedule of outstanding RSUs and related activity The following table sets forth the outstanding RSUs and related activity for the three months ended March 31, 2021:
Restricted Stock UnitsWeighted Average Grant Date Fair Value
(unaudited)
Unvested and outstanding at January 1, 2021
1,839,998 $34.17 
RSUs granted1,329,687 49.77 
RSUs vested186,329 33.70 
RSUs forfeited(45,666)35.50 
Unvested and outstanding at March 31, 2021
2,937,690 $41.24 
The following table sets forth the outstanding PRSUs, including executive PRSUs, and related activity for the three months ended March 31, 2021:
Performance-based Restricted Stock UnitsWeighted Average Grant Date Fair Value
(unaudited)
Unvested and outstanding at January 1, 2021
— $— 
PRSUs granted313,322 49.77 
PRSUs forfeited(5,463)49.77 
Unvested and outstanding at March 31, 2021
307,859 $49.77 
Schedule of the purchase right for the ESPP option assumptions
The fair value of the purchase right for the ESPP option component is estimated on the date of grant using the Black-Scholes model with the following assumptions for the three months ended March 31, 2021 and 2020:
Three Months Ended March 31,
20212020
(unaudited)
Expected volatility40.4%54.9%
Expected term (in months)66
Risk-free interest rate0.1%1.6%
Expected dividends